Clinical Trial Update: Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating infusion of genetically modified T cells in post-transplant patients with relapsed disease has completed. The study encompasse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Leukemia
• Multiple Myeloma
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Snippet

Sponsor: Washington University School of Medicine | Conditions: Leukemia, Lymphoma, Non-Hodgkin | Phase 1 | Status: COMPLETED